CIA vs RARE · P/E 15, rev $120.1M vs rev $350.0M
Citizens Inc (CIA) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Citizens Inc (CIA) is a insurance - life company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CIA revenue for 2026-06-30 was $120.1M. Net income was $1.8M. CIA currently screens at market cap $258.8M and trailing P/E 14.6.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CIA currently screens at market cap $258.8M and trailing P/E 14.6. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CIA and RARE stock pages for the full models.
Not investment advice.